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Abstract 
Background: The association of attention-deficit/hyperactivity disorder (ADHD) and tic disorder (TD) is 
frequent and clinically important. Very few and inconclusive attempts have been made to clarify if and 
how the combination of ADHD+TD runs in families.  
Aim: To determine the first time in a large-scale ADHD sample whether ADHD+TD increases the risk of 
ADHD+TD in siblings and, also the first time, if this is independent of their psychopathological 
vulnerability in general.  
Methods: The study included ADHD-index patients with co-existing TD (ADHD+TD, n=262) and 
without TD (ADHD-TD, n=947) as well as their 1606 full siblings (n=358 of the ADHD+TD index 
patients and n=1248 of the ADHD-TD index patients). We assessed psychopathological symptoms in 
index patients and siblings by using the strength and difficulties questionnaire (SDQ) and the parent and 
teacher Conners’ long version Rating Scales (CRS). For disorder classification the PACS-Interview was 
applied in n = 271 children. It was tested if the risk for ADHD, TD and ADHD+TD in siblings was 
associated with the related index patients’ diagnoses. In order to get an estimate for specificity we 
compared the four groups for general psychopathological symptoms. 
Results: Co-existing ADHD+TD in index patients increased the risk of both comorbid ADHD+TD and 
TD in the siblings of these index patients. These effects did not extend to general psychopathology.  
Interpretation: Co-existence of ADHD+TD may segregate in families (independent of further behavioral 
problems), probably because of the segregation of TD. This provides a new clinical aspect for 
psychoeducation in cases of ADHD+TD. 
 
Keywords: ADHD, tic disorders, comorbidity, familiality, IMAGE, SDQ, CRS-L 
 
What this study adds: 
1. ADHD+TD segregates in families probably because of the segregation of TD. 
2. This effect is not influenced by general psychopathology. 
3. Both results provide a new clinical aspect for a better psychoeducation in these cases. 
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Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder with a strong impact on the 
affected individual’s life, including academic difficulties, impaired socialization, and strained parent-child 
relationships.1 Both genetic2,3 and environmental4 factors play a role in the etiology of ADHD. The 
disorder  is accompanied by various psychiatric disorders.5 Research on familial underpinning of ADHD 
co-occurring with tic disorders (TD) is clinically important, since TD are commonly co-existing with 
ADHD. While about half of children with TD also meet criteria for ADHD6, about 20% of children with 
ADHD are additionally suffering from TD.7-9 
O’Rourke et al.10, while reporting from earlier studies on ADHD+TD, stated “that the increased 
frequency of ADHD in relatives of TD probands” may be due to the enhanced risk for ADHD+TD. The 
risk for ADHD alone was not increased among relatives of TD patients. However, these studies were 
limited by small sample sizes and lacking of families with probands diagnosed with ADHD-only. 
Only Stewart et al.11 compared the relatives of four different groups with each other (ADHD+TD vs. TD-
only vs. ADHD-only vs. healthy controls) and found that “comorbid ADHD+TD diagnoses in relatives 
were elevated in all case groups” and they concluded that “there is an increased risk of comorbid ADHD 
and TD in affected families.” Although this study suggests the existence of familiality of ADHD+TD, the 
small data base with limited sub-sample sizes demands further evaluation concerning (a) whether the 
pattern of ADHD+TD co-existence really runs in families and b) how disorder specific this might be.  
Since ADHD + TD is highly important in daily clinical practice (e.g. for psychoeducation, early 
prevention and treatment) it needs to be disentangled further. Therefore, it seems to be worthwhile 
elucidating the familiality of ADHD+TD. While taking an ADHD perspective, this study will extend the 
small empirical data base in order to better answer question (a) and add new knowledge to (b). 
 
Hence, we are running this study by analyzing for the first time a large sample of ADHD affected 
children and their (partly also affected) siblings, who took part in the IMAGE-study.12, 13 Based on 
previous findings (see above) we expected as a directed hypothesis (a) higher frequency of ADHD+TD in 
the similarly stratified siblings group of index patients with ADHD+TD vs. the siblings group with 
ADHD-TD, supporting the assumption that ADHD+TD may run in families and (b) a higher level of 
broad band psychopathology symptoms in siblings of index children with ADHD + TD compared to 
siblings of index children with ADHD-TD. The latter could reflect an estimate of disorder related 
specificity of our segregational findings (non-directed hypothesis).  
 
Methods and Materials   
Sample 
Families with at least one child with the combined subtype of ADHD (= index patient) and their full 
siblings (regardless of their possible ADHD-status) were recruited as part of the IMAGE (International 
Multi-center ADHD Genetics) study. IMAGE is a collaborative study that aims to identify genes that 
increase the risk of ADHD using linkage and association strategies. A detailed description of the IMAGE 
sample (including recruitment and exclusion criteria as well as ethical approval) has already been given in 
previous studies.12, 13 
Our sample included 2815 individuals consisting of 1209 index patients suffering from ADHD and 1606 
of their siblings. The higher number of siblings is due to the fact that some patients had more than one 
sibling who took part in the study.  
 
The index patients (in total N=1209) were allocated to the group ADHD+TD (N=262) if they fulfilled 
the criteria for both ADHD and TD; if TD-criteria were not fulfilled, they were classified as group 
ADHD-TD (N=947). 
The siblings of index patients (in total N=1606) were differentiated in those of index patients with 
ADHD-TD (N=1248) and siblings of index patients with ADHD+TD (N=358) regardless of their own 
diagnostic status. Further the 1606 siblings of index patients with ADHD (i.e. ADHD+TD and ADHD-
TD; see above) were screened themselves for ADHD with Conners’ Rating Scales and SDQ. In case of 
scores indicative for a diagnosis of ADHD a PACS interview (see Assessment below) has been conducted 
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and led to a diagnosis of ADHD in 131 siblings. Because the information about a TD diagnosis was taken 
from the PACS interview and this has been conducted only in those siblings for whom ADHD was 
assumed by screening, also the information about the occurrence of TD yes/no was available only for 271 
siblings (i.e. not all TD siblings without ADHD might have been detected). Among those siblings 41 were 
identified as being affected with TD (see flow chart Fig. 1).  
 
 
+++ figure 1 about here +++ 
 
 
Assessment  
The clinical assessment of dimensional psychopathology was performed with the long versions of 
Conners’ Rating Scales (CRS) for parents and teacher and the Strengths and Difficulties Questionnaires 
(SDQ) for parents and teacher. Scores were indicative for a diagnosis of ADHD if T-scores were ≥ 63 on 
the Conners’ DSM-IV ADHD Total score and if the score on SDQ Hyperactivity scale exceeded the 90th 
percentile. In these cases the semi-structured interview PACS (Parental Account of Childhood 
Symptoms)14 was executed for the assessment of diagnostic categories. During the PACS parents were 
asked for detailed descriptions of what their children have done in specified situations over the previous 
week. Based on these reports, trained investigators verified the ADHD diagnosis according to DSM-IV 
criteria. 
The PACS-interview also allowed the examination of the existence of a TD. For this purpose the parents 
were asked if their child showed some kind of tic behavior. In case they affirmed this question, the 
parents were requested to specify what kind of tics they had observed (simple/complex motor/vocal tics 
or both) and when these tics first occurred. A diagnosis of TD was given if the child showed tics a couple 
of times a day or almost every day.  
 
Measurements  
To assess the psychopathological profile of the children (index patients and their related siblings) parents 
and teachers had to complete the long versions of Conners’ Rating Scales – Revised (CPRS-R-L and 
CTRS-R-L respectively)15, 16 and the Strengths and Difficulties Questionnaire (SDQ-P and SDQ-T 
respectively).17 The CPRS-R-L is a well-established instrument to assess childhood behavior problems. 
We focused on five of its seven main scales (oppositional, social problems, anxious-shy, psychosomatic, 
perfectionism) as well as on its DSM-IV scales, (DSM-IV inattention, DSM-IV hyperactivity-impulsivity 
and DSM-IV total score) to examine the symptomatology of the children. The SDQ is a brief behavioral 
screening questionnaire with five primary scales (hyperactivity, conduct problems, peer problems, 
emotional problems and prosocial problems) which were all considered. All subjects had an estimated 
full-scale IQ above 80.18, 19 
 
Data analyses 
All data were statistically analyzed with SAS (Statistical Analysis System). 
To analyze the familial occurrence for each of the three conditions under investigation (ADHD, TD, 
ADHD+TD) we calculated the relative risk of sibling’s diagnoses in relation to both index patient-groups 
(ADHD-TD and ADHD+TD). The odds ratio served as a measure for the degree to which the relative 
risks of sibling’s diagnosis differed between both patient-groups. The method used was PROC 
GENMOD. 
To analyze the level of psychopathological symptoms a mean score was calculated for each Conners’ 
and SDQ scale named above. Because of some missing data from questionnaires and PACS interview the 
number of cases varied between the different psychopathological variables. 
An analysis of variances was conducted, including two factors: “proband-status” (index patients vs. 
siblings) and “disorder” (ADHD-TD vs. ADHD+TD). Index patients and siblings derived from the same 
families, so their data were partly dependent of each other. But they did not form a sample of matched 
pairs with one sibling being assigned to each index patient, because number of participating siblings per 
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family varied. Therefore we employed PROC GENMOD for generalized linear models – a SAS 
procedure able to handle partly dependent data. Additionally, follow-up comparisons analyzed patient-
groups and sibling-groups separately. The comparison of both index patients groups was accomplished 
with t-tests for descriptive purposes. For the case of inhomogeneous variances the degrees of freedom 
were approximated by the Welch-Satterthwaite equation. For comparison of the sibling-groups we used 
PROC GENMOD.  
 
Results 
Group characteristics 
Patients suffering from ADHD without TD (ADHD-TD: mean age 10.7 ± 2.8 years) did not differ in age 
from patients with ADHD+TD (mean age 11.1 ± 2.7 years, p = .06). Additionally, there were no 
differences in IQ between the two groups (ADHD-TD: mean IQ = 99.8 ± 16.2 vs. ADHD+TD: mean IQ = 
100.0 ± 15.6, p = .88). However, in the group of children with ADHD-TD the proportion of girls (14.5%) 
exceeded their proportion in the ADHD+TD-group (6.8%, p < .01).  
Siblings of index patients with ADHD-TD had a mean age of 10.8 ± 3.4 years and a mean IQ of 101.7 ± 
13.3. This did not differ from the mean age and IQ of the siblings whose related index patient suffered 
from ADHD+TD (mean age 10.7 ± 3.4 years, p = .42, and mean IQ 102.9 ± 13.3, p = .41). Also, there 
was no significant difference in gender between both groups (siblings of ADHD index patients 49.9% 
female vs. siblings of ADHD+TD index patients 52.0% female, p = .53). 
 
Frequency of disorder 
This analysis included different subsamples (see Fig. 1) of siblings, because information about the 
occurrence of a TD diagnosis was not available for all. Therefore each subsample of siblings of ADHD-
TD patients and each corresponding subsample of siblings of ADHD+TD patients were compared in 
terms of age, gender and IQ. No significant differences between the quasi-experimental-conditions were 
found in any of siblings’ subsamples. 
 
+++ table 1 about here +++ 
 
For the first analysis of familial transmission the relative risk for ADHD did not differ between siblings of 
index patients with ADHD+TD and siblings of index patients suffering from ADHD without TD (p = .38, 
see table 2, crosstab 1). 
For the second analysis, the relative risk for TD tended to differ between siblings of index patients with 
ADHD+TD and siblings of index patients suffering from ADHD without TD (p=.07, see table 2, crosstab 
2).  
For the third analysis, siblings of index patients with ADHD+TD had a statistically significant 2.43-fold 
higher risk for ADHD+TD than siblings of index patients with ADHD (p=.04, see table 2, crosstab 3).  
 
Level of psychopathology  
The two-factorial analyses of variance revealed a significant main effect for “proband-status” with regard 
to all of the psychopathological symptoms. In contrast, no main effect for “disorder” was found except for 
prosocial behavior rated by parents. The interaction effect was significant on four scales of the CPRS-R-L 
(oppositional: p < .01, social problems: p < .01, anxious-shy: p < .01, perfectionism: p = .01) and on three 
scales of the SDQ-P (conduct problems: p = .01, peer problems: p = .01, emotional problems: p = .01). In 
teacher ratings the interaction only reached significance on the CTRS-R-L DSM-IV total score (p = .05) 
(see table 2).  
The pairwise comparisons showed significant differences between index-patients with ADHD-TD and 
those with ADHD+TD on most of the psychopathological measures. Parents rated ADHD+TD children as 
more impaired than children suffering from ADHD-TD. In contrast to the parents’ assessment, teachers 
rated patients with ADHD as showing significantly more severe symptoms of psychopathology than 
patients suffering from ADHD+TD. For parent as well as teacher ratings effect-sizes were small ranging 
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from 0.05 to 0.32. There were no significant differences between the still normal-range values of their 
siblings (see table 2). 
 
+++ table 2 about here +++ 
 
 
Discussion   
The main aim of our study was to investigate the familiality of comorbid ADHD+TD. Hence, we 
examined the frequency of occurrence of three disorders, namely ADHD, TD and ADHD+TD in full 
siblings of index patients with ADHD-TD respective ADHD+TD. Both groups were investigated in a 
large European sample of ADHD-affected families.12, 13 In order to consider the issue of disorder related 
specificity of probable familiality effects, we also compared general psychopathology between groups.  
 
Frequency of disorder  
We found that the familial risk for ADHD was not different in both sibling groups, i.e. if TD is added to 
ADHD (in the ADHD+ TD groups) it does not seem to increase the risk of ADHD. In other words, in this 
case ADHD is the leading vulnerability marker. 
In contrast, and this is our main finding, there was a significantly higher risk of ADHD+TD (and a 
tendency for TD) among siblings of patients with ADHD+TD. This suggests that the  familiality of 
ADHD+TD may exist probably driven by TD.  
 
To our knowledge there is only one study which examined the occurrence of ADHD+TD in relatives of 
ADHD+TD-patients.11 It included 239 probands (mean age 13.8) and 692 first-degree relatives in total. 
The number of cases in each proband-group varied between 41-75 and between 114-219 in the relative-
groups. Stewart et al.11 reported that ADHD+TD was increased not only in relatives of the ADHD+TD 
group but also in relatives of the TD-only and ADHD-only case groups supporting the assumption of a 
cross-disorder vulnerability and familiality of ADHD+TD. However, in Stewart et al.11 (see adaptation of 
their data in O’Rourke et al.10, table 1) the first degree relatives of the ADHD+TD proband groups vs. the 
ADHD-only group show higher frequencies for TD as well as ADHD+TD. Including our data, it seems 
probable that TD might be the essential factor for the familiality of both TD and ADHD+TD; i. e. so far 
there is no clear evidence for a strong common vulnerability of ADHD and TD respectively. Hence, the 
“true comorbidity” explanation of ADHD+TD is suggested, which is supported by psychopathological, 
neuropsychological and neurophysiological findings pointing merely to an association than to a clinical 
entity of ADHD+TD.20, 21 
 
Level of psychopathology  
Parallel to the analysis of the index patients’ categorical psychopathology by diagnoses, we assessed the 
dimensional psychopathological profile in the patients’ siblings in order to get a rough estimate of 
specificity. In contrast to the comparisons of affected index children (ADHD-TD showed less symptoms 
than ADHD+TD), we did not find any differences comparing the values of siblings of ADHD-TD 
patients vs. siblings of ADHD+TD patients which all were within the normal range. Thus, the assumption 
of higher general psychopathological vulnerability in siblings of index patients with ADHD+TD (as a 
first hint of familiality) was not supported on the basis of dimensional psychopathology and underlines 
that TD adds little to psychic problems when it co-exists with ADHD.20  
For parent as well as teacher ratings the effect sizes while comparing patients with ADHD-TD and those 
with ADHD+TD were small. This could be due to the uncertainty of these non-expert raters in 
differentiating the children’s behavior because there can exist some mimicry of symptoms in ADHD and 
TD concerning hypermotricity, inattention and impulsiveness.  
Teachers’ ratings were found somewhat opposite to parents’ ratings. , Although there are several reports 
about different outcomes of parents’ versus teachers’ ratings of ADHD core-symptoms, this issue is still 
not resolved.22 Further, it is clinically a well-known fact that children with TD (including those with 
ADHD+TD) are very often able to control their symptoms at school and “let them out” when they are at 
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home. Therefore specifically hyper-motor behaviour and impulsivity might be hidden at school and quite 
obvious at home. Thus, when comparing teacher and parent ratings of ADHD-TD versus ADHD+TD 
patients, environmental/informant influences might explain the difference.  
 
Limitations   
There are some limitations of the study that need to be mentioned. 
The gender ratio differed between both index patients groups. Among the patients suffering from 
ADHD+TD there was a higher percentage of boys compared with the ADHD-TD group. Although this 
seems to be a natural fact of ADHD+TD8, 9 this might have somewhat biased the results towards 
externalizing behaviors, because ratings of psychopathological symptoms are not independent of gender. 
As we analyzed index patients and siblings sharing family environment only interpretations referring to 
familiality but not heritability and/or genetic background are possible.  
Further, our study design included only two index patient-groups (ADHD-TD and ADHD+TD). In order 
to comment on more specific modes of familiality it would be necessary to additionally include a TD-only 
and a healthy control-group.  
 
Conclusions 
Our results suggest that ADHD+TD may run in families and that the vulnerability for this might be 
related to TD. The TD-specificity of our finding is supported by the fact, that TD-only ran also in families 
and that general psychopathology did not show familiality effects. It remains to be clarified if this familial 
TD-effect may be influenced by obsessive-compulsive symptoms (which often exist together with ADHD 
as well as TD), because there is some evidence that association between TD and ADHD “may be due to a 
genetic association between OCD and ADHD and in part to shared environmental factors”.23,10 
Unfortunately, our data set did not allow to test this hypothesis. Whether our significant interaction effect 
between ‘proband status’ and ‘disorder’ for perfectionism (CPRS-R-L) reflects a signal in this direction 
remains to be left open. Also, our findings do not allow to firmly conclude if ADHD+TD should best be 
seen as an additive combination of two separate nosologies or if it should be considered a distinct subtype 
within a heterogeneous disorder, but recent research at different levels of investigation suggests merely 
the additive variant.8, 20 Finally, the issue that familiality of ADHD+TD may be driven by TD 
(independent of further behavioral problems) provides a new clinical aspect for psychoeducation in these 
cases. 
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ADHD 
patients 
ADHD+TD  
patients 
 
 
 
ADHD 
siblings 
ADHD+TD  
siblings 
  
two-factorial analysis 
disorder 
proband-
status 
inter-
action 
  M SD M SD t  M SD M SD  Z  Z Z Z 
CRS-parents                   
oppositional behaviour  70.5 12.4 73.3 11.8 -3,37**  55.6 13.4 54.6 12.0  0,94   1,12 20,35** -3,49** 
DSM-IV inattention  70.9 9.0 71.1 8.1 -1,51  54.9 12.5 55.5 12.6 -0,88  -0,87 19,03** -0,18 
DSM-IV hyperactiv-
impulsiv 
 80.6 10.3 82.0 8.5  2,33*  56.6 14.7 56.2 14.1  0,11   0,27 28,89** -1,58 
DSM-IV total  77.6 9.0 78.9 8.1 -2,20*  56.4 12.6 56.4 13.0 -0,63  -0,54 20,29** -0,81 
anxious/shy behaviour  58.7 13.8 63.1 14.4 -4,42**  53.1 12.1 53.0 12.1 -0,50  -0,21 9,69** -3,65** 
psychosomatic symptoms  59.7 15.2 61.6 16.4 -1,68+  53.8 13.3 54.2 14.3 -0,44  -0,49 6,18** -1,08 
perfectionism  55.7 11.9 58.1 13.0 -2,67**  49.8 9.3 49.4 9.2  0,87   0,93 10,17** -3,10** 
social problems  67.0 15.0 71.0 14.5 -3,92**   53.4 11.8 53.4 11.6  0,00   0,03 16,39** -3,29** 
SDQ-parents                 
hyperactivity  8.4 1.7 8.7 1.5 -2,43*  3.4 3.1 3.4 3.0 -0,20  -0,09 27,14** -1,10 
conduct problems  4.6 2.4 5.1 2.4 -2,94**  2.9 2.1 2.9 1.7  0,84   1,00 18,91** -3,19** 
emotional problems  3.7 2.5 4.3 2.6  3,22**  2.4 2.3 2.3 2.4  0,23   0,34 10,84** -3,07** 
peer problems  3.9 2.6 4.5 2.7 -3,37**  1.7 1.9 1.7 2.0 -0,42  -0,29 14,69** -2,71** 
prosocial behaviour  6.9 2.3 6.3 2.3  3,08**  8.1 2.0 7.9 2.1  1,81*   1,77* -8,57**  1,23 
CRS-teacher                  
oppositional behaviour  66.8 14.4 64.9 13.8  1,89+  55.3 12.9 54.8 12.8  0,56   0,61 9,94**  1,13 
DSM-IV inattention  63.2 10.5 61.9 10.6  1,73+  54.8 11.4 55.3 11.8 -0,64  -0,63 7,46**  1,78+ 
DSM-IV hyperactiv-
impulsiv 
 71.7 11.9 69.6 11.0  2,64**  56.6 13.0 55.9 13.0  0,67   0,85 14,00**  1,19 
DSM-IV total  70.8 10.6 68.7 10.3  2,80**  55.7 13.8 56.1 13.8 -0,09  -0,00 13,28**  1,93* 
anxious/shy behaviour  65.0 12.8 63.7 11.9  1,55  59.2 12.6 58.4 11.7  0,90   1,00 5,81**  0,51 
perfectionism  56.9 11.6 55.8 11.4  1,33  52.4 9.4 52.2 9.2  0,52   0,66 4,46**  0,73 
social problems  60.0 13.7 61.1 13.4 -0,51  52.9 11.5 52.6 10.8  0,26   0,51 8,41** -0,76 
SDQ-teacher                 
hyperactivity  7.8 2.1 7.7 2.2  0,88  3.8 3.1 3.8 3.1  0,43   0,51 19,10**  0,15 
conduct problems  3.2 2.3 3.0 2.5  1,13  1.4 1.9 1.4 1.8  0,73   0,82 9,86**  0,51 
emotional problems  3.0 2.4 2.7 2.3  1,94*  2.0 2.2 1.8 2.1  1,42   1,48 5,17**  0,61 
peer problems  3.1 2.5 3.3 2.7 -0,97  1.7 2.0 1.5 1.8  1,39   1,57 9,80** -1,79+ 
prosocial behaviour  5.7 2.7 5.2 2.6  2,84**  7.3 2.4 7.1 2.5  0,88   0,87 9,54**  1,71+ 
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Table 1: Psychopathological profile 
CRS: Conners’ Rating Scales – Revised (Conners, Sitarenios et al. 1998; Conners, Sitarenios et al. 1998) 
SDQ: Strengths and Difficulties Questionnaire (Woerner, Becker et al. 2004) 
M: mean, SD: standard deviation, t: test statistic (t-test), Z: test statistic (PROC GENMOD) 
** p < .01, * p < .05, + p < .10 
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patients  siblings  
relative 
risk 
 
odds ratio 
(p-value) 
crosstab 1 
       
 no ADHD a) ADHDa)     
ADHD  111 98  0.88 
 
1.29 (.38) 
ns ADHD+TD  29 33  1.14 
crosstab 2 
       
 no TDb) TDb)     
ADHD  182 27  0.15 
 1.97+(.07) 
ADHD+TD  48 14  0.29 
crosstab 3 
       
 no ADHD/ no TD ADHD+TD     
ADHD  98 14  0.14 
 2.43*(.04) 
ADHD+TD  23 8  0.35 
 
Table 2: Frequency of siblings’ ADHD and/or TD diagnoses independently of further diagnoses based on 
Parental Account of Children's Symptoms (PACS) interview.   
Note: Siblings were screened for a previous ADHD diagnosis, clinical suspicion of ADHD, an average T-
score of the DSM-IV total symptom score (N-scale) greater than 63 on the Conners scales or scores >90th 
percentile on the SDQ-hyperactivity scale. Only in verified cases the semi-structured PACS interview was 
performed leading to diagnosis based on operational DSM-IV criteria for ADHD and/or TD.  
a) independently of TD status of the siblings  
b) independently of ADHD status of the siblings 
Data in cells: absolute frequencies, * p < .05, + p < .10, ns: non-significant  
crosstab 1 and 2: two-tailed; non-directed hypothesis  
crosstab 3: one-tailed, directed hypothesis 
 
 
